Oriola Oyj julkistaa osavuosikatsauksen kaudelta 1.1.–31.3.2021 tiistaina 27.4.2021 noin klo 8.30. Oriola Oyj järjestää tuloksen julkistamistilaisuuden sijoittajille, analyytikoille ja lehdistölle tiistaina 27.4.2021 klo 10.00 suorana webcast-lähetyksenä.

Mar 16, 2021 Oriola Corporation Managers' transactions March 16, 2021 at 1:00 p.m.. Oriola Corporation - Managers' transactions - Kariniemi

Distributed by Public, unedited and unaltered, on 27 April 2021 05:38:04 UTC. 2021-03-16 18:00 · Cision Oriola Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset; 2021-03-16 18:00 · Cision Oriola Oyj: Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors 2020-08-27 · Stock analysis for Oriola Oyj (OKDBV:Helsinki) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aktien Oriola Oyj B med ISIN-beteckning FI0009014351. Jag skriver om aktier, fonder och sparande kring mitt mål att bli ekonomiskt fri. Oriola Oyj: Oriola Corporation - Johdon liiketoimet. Publicerad: 8 mars 2021, 15:00 (Cision) Oriola Oyj: Oriola Corporation - Johdon liiketoimet.

klo 8.30 - 16.30) Puh. hinta: 8,4 snt/min, sis alv 24% Stock analysis for Oriola Oyj (OKDAV:Helsinki) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-03-16 Oriola Oyj - Wholesale of pharmaceutical goods. Nordic Market Data AB. Waterfront Building Klarabergsviadukten 63 SE-101 23 Stockholm Oriola Oyj has 64 employees at this location and generates $1.90 billion in sales (USD). There are 358 companies in the Oriola Oyj corporate family. D&B Hoovers provides sales leads and sales intelligence data on over 120 million companies like Oriola Oyj around the world, including contacts, financials, and competitor information. ORIOLA OYJ : News, information and stories for ORIOLA OYJ | Nasdaq Helsinki: OKDBV | Nasdaq Helsinki Oriola Oyj, Espoo, Finland.

3 brokers rate it as a ' Hold'. Click to view HEX:OKDBV's StockReport. Oriola is a health and wellbeing company operating in the Nordic countries.

Det finska läkemedelsbolaget Oriola blir av med sin vd Robert Andersson som slutar omgående, enligt ett pressmeddelande. Andersson kvarstår som rådgivare fram tills 31 juli. Han har varit vd de senaste tre åren. Oriola har inlett sökprocessen efter en ny vd. Under tiden tar styrelseledamoten Juko Hakala över som tillförordnad vd.

Oriola's customers are comprised of Katarina Gabrielson (Vice President Ba Retail) | Kimmo Savolainen (Director, Site Operations Finland) | Audrius Pivoras (Managing Director at Uab Oriola Oriola Oyj: Resolutions of the Annual General Meeting of Oriola Corporation and the decisions of the constitutive meeting of the Board of Directors. 16.3.2021 klo The company's Wholesale and Distribution division is represented by Oriola in Finland and Kronans Drughandel (KD) in Sweden, which together account for 72 2 päivää sitten Oriola Corporation stock exchange release 27 April 2021 at 8.30 a.m.. Q1 2021: Profit weakened due to the increased demand volatility of the Oriola Oy Johto Ja Hallinto in Espoo, reviews by real people. Yelp is a fun and easy way to find, recommend and talk about what's great and not so great in 6 days ago O5O (Oriola Oyj) historical prices and fundamental data API. Stock historical prices and Fundamental Data API. More than 60+ stock exchanges Feb 25, 2021 No description defined.

Oriola Oyj on perustettu vuonna 2006. Se on julkinen osakeyhtiö, jonka kotipaikka on Espoo , ja pääasiallinen toimiala Tukkuliike . Yhtiön toimitusjohtaja on Juko-Juho Raikko Hakala.

In Sweden, Oriola owns the country's third-largest pharmacy chain, Kronans Oriola's supply chain ensures reliable and safe delivery of pharmaceuticals to Oriola Oyj B. ISIN FI0009014351; Closed.

Oriola-KD Oyj akcijas tiek kotētas Helsinku biržā kopš 2006. gada 3. jūlija. Oriola Oyj (OKDBV:HEX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. 21 hours ago Oriola Oyj Series B company facts, information and financial ratios from Executive Officer by Konecranes Oyj, a Chairman by Ahlstrom Oyj, View today's stock price, news and analysis for Oriola Oyj Series A (OKDAV). Barron's also provides information on historical stock ratings, target prices, Get the latest Oriola Oyj Class A (OKDAV) real-time quote, historical performance , charts, and other financial information to help you make more informed trading Oriola Oyj ORIOLA CORPORATION B ORD SHS. ×.
Patrik rees

Oriola tarjoaa palveluita sekä terveys- ja hyvinvointituotteita lääkeyhtiöille, apteekeille ja muille alan toimijoille sekä kuluttajille. Oriola Oyj provided a TSR of 22% over the last twelve months. But that was short of the market average. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 8% endured over half a decade.

0.03 (1.432%). Currency in EUR Oriola Oyj (OKDBV:HEX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Latest Oriola Oyj (OKDAV:HEX) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. OKDAV | Complete Oriola Oyj Series A stock news by MarketWatch.
Ungdomsmottagning hallsberg

2020-08-27 · Stock analysis for Oriola Oyj (OKDBV:Helsinki) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avantis International and ORIOLA OYJ into the same portfolio, which is an essential part of the Oriola Oyj is located in ESPOO, Uusimaa, Finland and is part of the Drug Wholesalers Industry. Oriola Oyj has 64 employees at this location and generates $1.90 billion in sales (USD). There are 358 companies in the Oriola Oyj corporate family. Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden.